Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Summary
The purpose of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with newly diagnosed [ND] multiple myeloma (MM) and participants with relapsed/refractory [R/R] MM.
Full Description
This is a prospective, non-interventional, observational study. This study will look at contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with MM. Participants will not be asked to change their routine clinical treatment. Participants will have to complete patient reported outcomes (PROs) surveys during on-site routine office visits.
The study will enroll approximately 4200 participants. Participants will be assigned to one of the following cohorts based upon the diagnosis of MM:
ND MM within 3 months from initiation of treatment
R/R MM who have received 1 to 3 prior lines of therapy
This multi-center trial will be conducted worldwide. The overall time to participate in this study is up to 8 years. Participants will be evaluated and followed-up for a period of at least 5 years, until death, are lost to follow-up, or the end of the study, whichever comes first.
Eligibility Criteria
Inclusion Criteria:
Is 18 years of age or older.
Is experiencing the following:
Newly diagnosed MM within 3 months from initiation of treatment with documented month and year of diagnosis, criteria met for diagnosis, stage, and MM-directed treatment history, including duration, or
Relapsed/refractory MM who have received 1 to 3 prior lines of therapy with documented data in the medical record regarding diagnosis (month and year), the regimens used in 1st, 2nd, and 3rd line as applicable, whether stem cell transplant was part of 1st, 2nd, and 3rd line of therapy, whether consolidation/maintenance was part of 1st, 2nd, and 3rd line of therapy, also whether investigational therapy/treated on a clinical trial was part of any of these regimens.
Is willing and able to sign informed consent to participate. Is willing and able to complete patient-reported outcomes (PROs) in accordance with local regulatory and data protection requirements.
Exclusion Criteria:
Is reporting to a site in this study for a second opinion (consultation only) or participants whose frequency of consult and follow-up are not adequate for quarterly electronic case report form (eCRF) completion.
Has participated in another study (observational or interventional) that prohibits participation in this study.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 103 Locations for this study
Little Rock Arkansas, 72205, United States
Little Rock Arkansas, 72205, United States
La Jolla California, 92093, United States
Santa Rosa California, 95403, United States
Denver Colorado, 80218, United States
Fort Collins Colorado, 80528, United States
Washington District of Columbia, 20037, United States
Daytona Beach Florida, 32117, United States
Fort Myers Florida, 33916, United States
Saint Petersburg Florida, 33705, United States
Niles Illinois, 60714, United States
Indianapolis Indiana, 46202, United States
Metairie Louisiana, 70006, United States
Lewiston Maine, 04240, United States
Columbia Maryland, 21044, United States
Detroit Michigan, 48201, United States
Saint Louis Park Minnesota, 55416, United States
Bolivar Missouri, 65613, United States
Kansas City Missouri, 64128, United States
Saint Louis Missouri, 63110, United States
Flemington New Jersey, 08822, United States
Farmington New Mexico, 87401, United States
East Hills New York, 11576, United States
New York New York, 10029, United States
Charlotte North Carolina, 28402, United States
Cincinnati Ohio, 45220, United States
Medford Oregon, 97504, United States
Portland Oregon, 97227, United States
Philadelphia Pennsylvania, 19111, United States
Pittsburgh Pennsylvania, 15240, United States
Greenville South Carolina, 29615, United States
Nashville Tennessee, 37203, United States
Amarillo Texas, 79106, United States
Dallas Texas, 92056, United States
El Paso Texas, 79902, United States
Houston Texas, 77030, United States
Round Rock Texas, 78681, United States
San Antonio Texas, 78217, United States
Yakima Washington, 98902, United States
Martinsburg West Virginia, 25401, United States
Green Bay Wisconsin, 54307, United States
Madison Wisconsin, 53792, United States
Milwaukee Wisconsin, 53215, United States
Charleroi , 6000, Belgium
Gent , 9000, Belgium
Haine-Saint-Paul , 7100, Belgium
Leuven , 3000, Belgium
Liege , 4000, Belgium
Yvoir , 5530, Belgium
Campinas , 13083, Brazil
Florianopolis , 88034, Brazil
Goiania , 74680, Brazil
Rio de Janeiro , 21941, Brazil
Salvador , 40110, Brazil
Sao Paulo , 04537, Brazil
Sao Paulo , 05651, Brazil
Sao Paulo , 54030, Brazil
Beijing , 10073, China
Beijing , , China
Hangzhou , 31000, China
Suzhou , 21500, China
Bogota , , Colombia
Floridablanca , , Colombia
Medellin , , Colombia
Monteria , , Colombia
Bayonne , 64109, France
Le Mans , 72000, France
Perigueux , 24019, France
Poitiers , 86021, France
Roche-sur-Yon , 85000, France
Vandoeuvre-les-nancy , 54211, France
Chemnitz , , Germany
Dortmund , , Germany
Heidelberg , , Germany
Herrsching am Ammersee , , Germany
Koblenz , , Germany
Mainz , , Germany
Mannheim , , Germany
Marburg , , Germany
Siegburg , , Germany
Tubingen , , Germany
Alexandroupoli , 68100, Greece
Athens , 10676, Greece
Athens , 11525, Greece
Ioannina , 45500, Greece
Larisa , 41110, Greece
Patras , 26500, Greece
Afula , 18371, Israel
Haifa , 34362, Israel
Jerusalem , , Israel
Kefar-Sava , 44281, Israel
Tel Aviv , 64239, Israel
Tel Aviv , 69710, Israel
Ancona , 60020, Italy
Bologna , 40138, Italy
Catania , , Italy
Firenze , 50134, Italy
Napoli , , Italy
Roma , 00161, Italy
Torino , , Italy
Udine , 33100, Italy
Guadalajara , 44670, Mexico
Huixquilucan , , Mexico
Mexico City , 14000, Mexico
Monterrey , 64460, Mexico
Barcelona , 8036, Spain
Granada , 18014, Spain
Leon , 24080, Spain
Madrid , 28041, Spain
Salamanca , 37007, Spain
Valencia , , Spain
Puzi Chiayi County, 613, Taiwan
Kaohsiung , 807, Taiwan
Kaohsiung , , Taiwan
Taichung City , 40447, Taiwan
Tainan , 70403, Taiwan
Taipei , 10002, Taiwan
Adana , , Turkey
Ankara , , Turkey
Antalya , , Turkey
Gebze , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Izmir , , Turkey
Kayseri , , Turkey
Samsun , , Turkey
Trabzon , , Turkey
Leeds West Yorkshire, LS1 3, United Kingdom
Bath , , United Kingdom
Birmingham , B15 2, United Kingdom
Birmingham , B9 5S, United Kingdom
Bournemouth , Bh7 7, United Kingdom
Dundee , DD1 9, United Kingdom
Leicester , LE1 5, United Kingdom
Nottingham , NG5 1, United Kingdom
Sutton , SM2 5, United Kingdom
Wakefield , WF1 4, United Kingdom
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.